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A variety of mtDNA mutations responsible for human diseases have been associated with molecular defects in the
OXPHOS system. It has been proposed that mtDNA genetic alterations can also be responsible for sperm dys-
function. In addition, it was suggested that if sperm dysfunction is the main phenotypic consequence, thesemutations
could be fixed as stable mtDNA variants, because mtDNA is maternally inherited. To test this possibility, we have
performed an extensive analysis of the distribution of mtDNA haplogroups in white men having fertility problems.
We have found that asthenozoospermia, but not oligozoospermia, is associated with mtDNA haplogroups in whites.
Thus, haplogroups H and T are significantly more abundant in nonasthenozoospermic and asthenozoospermic
populations, respectively, and show significant differences in their OXPHOS performance.
Introduction
There is increasing evidence showing that spermmotility
is strongly dependent on the ATP supplied by the mi-
tochondrial oxidative phosphorylation system (OX-
PHOS) (Ford and Harrison 1981; Halangk et al. 1985;
Pascual et al. 1996; Ruiz-Pesini et al. 1998). Four of the
five enzymatic complexes that constitute the OXPHOS
system are partially encoded by mitochondrial DNA
(mtDNA). Thus, mutations in mtDNA genes that impair
the expression of one or more proteins encoded in the
mtDNA can promote diseases in humans (Enriquez et
al. 1995; Larsson and Clayton 1995; Wallace 1995;
Schon et al. 1997; Zeviani and Antozzi 1997). Accord-
ingly, it has been proposed that mutations in the mtDNA
affecting the performance of mitochondria ATP pro-
duction could cause reduced sperm motility and, there-
fore, asthenozoospermia (Følgero et al. 1993; Kao et al.
1995; Frank and Hurst 1996; St. John et al. 1997; Zev-
iani and Antozzi 1997). About 10%–13% of couples
suffer from infertility, which is caused by male dysfunc-
tion in 40% of the cases. Untreatable subfertility caused
by poor semen quality accounts for 75% of patients
consulting for fertility problems. This is due mainly to
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a low number of sperm cells (oligozoospermia) or to
asthenozoospermia (Baker 1994).
The frequency of the known pathological mtDNA
mutations within the population is insufficient to ex-
plain a significant proportion of the asthenozoospermic
patients. However, it was recently proposed that if
sperm dysfunction is the main, or the only phenotypic
consequence of a mtDNA mutation, those mutation(s)
could be fixed as stable mtDNA haplotype(s) or even
haplogroup(s). This could be possible due to the fact
that mtDNA is maternally inherited, and would not
suffer selective pressure throughout the male lineage
(Frank and Hurst 1996). Therefore, these mutations
could be accumulated within a population in a relatively
high proportion. We have investigated this possibility
by analyzing the distribution of CaucasianmtDNAhap-
logroups (Wallace 1995; Brown et al. 1997; Hofmann
et al. 1997b, 1997c; Richards et al. 1996; Torroni et
al. 1996, 1997) in men having fertility problems.
Material and Methods
Semen Collection and Analysis
Donors from the area of Madrid and Zaragoza (Spain)
were asked to collect semen by masturbation under hy-
gienic conditions, after a period of sexual abstinence of
3–5 d. The samples were analyzed following standard
protocols (WHO 1992) within a period of 2 h at hospital
fertility facilities. They were allowed to liquefy for 30 min
at 37C. Then the volume of the ejaculate was measured,
and the number and percentage of motile spermatozoa
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was evaluated (WHO 1992). In particular, sperm-motility
analysis was performed at room temperature, a minimum
of four microscopy fields were systematically scanned and
the motility of each spermatozoon graded as “a,” “b,”
“c,” or “d,” according to whether it showed rapid pro-
gressive motility, slow or sluggish progressive motility,
nonprogressive motility, or no motility at all. The per-
centage of spermatozoa in each category was estimated
after 100 spermatozoa were counted.
Spermatozoa morphology was assessed by optic mi-
croscopy. The proportion of sperm cells with apparent
head defects (large heads, small heads, and tapering
heads), midpiece malformations, or tail abnormalities
(multiple tails or coiled tails) was estimated. Samples
showing sperm cell agglutination, severe flagellar de-
fects, or very high semen viscosity were discarded.
Flagella-Activity Measurements
The activity of several mitochondrial OXPHOS com-
plexes was inhibited by increased concentrations of ro-
tenone (an inhibitor for the NADH dehydrogenase or
complex I-EC 1.6.5.3), antimycine A (an inhibitor for the
cytochrome c reductase or complex III-EC 1.10.2.2), or
cyanide (inhibitor for the cytochrome c oxidase or com-
plex IV- EC 1.9.3.1) and the proportion of sperm cells
able to manifest any kind of flagella activity was moni-
tored by microscopy cell count in a Neubauer chamber
after 3 min in the presence of the drug. In order to main-
tain a short and homogenous timing between the different
measurements, several microscopic fields in each sample
were video recorded for further quantification.
Spermatozoa Vertical Progression
Spermatozoa vertical progression was estimated by
vertical introduction of a capillary tube filled with a
4.8% glucose isotonic solution to a semen sample and
allowance of the entrance of the spermatozoa for 30min.
After that period of time, the distance (in mm) that the
spermatozoa were able to progress along the capillary
tube was estimated.
DNA Analysis and Sequencing
Mitochondrial DNA levels were estimated as follows:
∼0.5 mg of total DNA, extracted from semen and pre-
viously denaturalized with 0.5 M NaOH, was trans-
ferred to a nylon filter by Slot-Blot. Then, filters were
hybridized for the first time with a 273-bpmitochondrial
probe against the 16S mt-rRNA gene (nt 1621–1894).
The same filter was rehybridized, after stripping, with a
431-bp nuclear probe against the 18S n-rRNA gene (nt
757–1188). Probes were labeled by PCRwith 32[P]-dTTP
(Amersham). Filters were hybridized with 500,000–
1,000,000 counts per minute/ml of the appropriate
probe. Hybridization was performed in 6# SSC at 68C
and the blots were exposed for fluorography. Autora-
diograms were evaluated by a LKB laser densitometer
(model ULTROSCAN XL), with GelScan XL software.
DNA sequencing was performed by the Thermo Se-
quenase radiolabeled terminator cycle sequencing Kit
(Amersham) as specified by the manufacturer.
Haplogroup Determination
The samples were haplogrouped by PCR amplification
of short mtDNA fragments, followed by restriction en-
zyme analysis, as described elsewhere (Torroni et al.
1996), but with some modifications (table 1). Thus, we
have used the nomenclature proposed by the Emory
group, with minor modifications (Wallace 1995; Torroni
et al. 1996; Brown et al. 1997; Torroni et al. 1997). In
particular, since it has been recently proposed that the
haplogroup previously designated as “K” belongs to the
haplogroup U and should be considered a sub haplo-
group of it (Macaulay et al. 1999), we have joined the
individuals of K and U haplogroups and designated them
as “haplogroup KU.” In addition, we have reduced the
number of the polymorphic sites screened in all samples
to four specific positions: the 7025 AluI, 10394 DdeI,
and 12308 HinfI sites (Torroni et al. 1996) and the 4216
AflIII site.
These four polymorphic sites allow the classification
of individuals into four groups: those who belong to
haplogroups H, KU, and T–J, and those who belong to
haplogroups L, M, I, W, X, and V (Torroni et al. 1996,
1997). The identity of the haplogroups T and J was
further established by the analysis of additional poly-
morphic sites as indicated in table 1. Because of the low
ratio of mtDNA/nDNA present in spermatozoa, PCR
conditions were optimized in order to avoid amplifica-
tion of mitochondrial pseudogenes. Screening for the
T10463C and the G15928A polymorphisms was per-
formed by RFLP analysis, as described elsewhere
(Houshmand et al. 1994). The G15928A polymorphism
was confirmed by DNA sequencing. A full description
of the oligodeoxynucleotides utilized and the PCR am-
plification conditions are available upon request.
Biochemical Determinations
Semen samples (0.5–2 ml) were centrifuged for 10 min
at 600 # g at room temperature. Seminal plasma was
collected for the biochemical determinations. Fructose
and citric acid concentration were determined by spec-
trophotometry in an Hitachi autoanalyzer, using standard
kits (Boehringer Mannheim catalogue numbers 139106
and 139076) according to the supplier’s specifications.
Carnitine concentration was estimated as previously de-
scribed (Rodriguez-Segade et al. 1985). The concentration
of different metals (calcium, zinc, and magnesium) was
estimated at the hospital facilities by atomic absorption.
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Table 1
MtDNA Polymorphic Sites Used to Define the mtDNA Haplogroups
MTDNA
HAPLOGROUP
RESULTS AT SITEa
7025AluI 12308HinfI 4216AflIII 4914MaeI 13366BamH1 13704MvaI 8249AvaII
H   / ND/ ND/ ND/ ND
V    ND ND ND 
KU    ND ND ND ND
J       ND
T       ND
I    ND ND  
W    ND ND ND 
X    ND ND ND 
M    ND ND  
L    ND ND  
O    ND ND  
NOTE.—The presence of the indicated restriction-enzyme polymorphic sites was investigated in short PCR fragments amplified from mtDNA.
The plus sign () indicates that the enzyme is able to cut the amplified PCR fragment, and the minus sign () indicates that it is not. The plus/
minus sign () indicates that there are members of these haplogroups that could, or could not, be cut by the enzyme. Results following a slash
(/) apply to only a few individuals. The names of the haplogroups are as described elsewhere (Macaulay et al. 1999), except for O, which
corresponds to a set of unassigned individuals.
a nd p not determined.
Enzyme Activity Analysis
At room temperature, 0.5–2 ml of semen was centri-
fuged for 10 min at 600# g. Seminal plasma was elim-
inated and the pellet was washed with saline solution.
Samples were centrifuged again for 10 min at 600# g,
supernatants were discarded, and the spermatozoa were
resuspended in the required volume of 20mMpotassium
phosphate (pH 7.0) to reach a final concentration of 2
# 105 cells/ml. Then samples were homogenized by
freeze thawing before analysis, as described elsewhere
(Ruiz-Pesini et al. 1998). The activities of NADH de-
hydrogenase (NADH DH, complex I), succinate dehy-
drogenase (complex II- EC 1.3.99.1), cytochrome c
oxidase (COX, complex IV), and citrate synthase (CS-
EC 4.1.3.7) in spermatozoa homogenatesweremeasured
spectrophotometrically in a Beckman DU-650 spectro-
photometer (Beckman Instruments) by monitoring the
reduction of ferricyanide (complex I), 2,6 diclorophen-
olindophenol (DCPIP) (complex II), the oxidation of cy-
tochrome c (complex IV) or the condensation of dition-
itrobenzoate (DTNB) with free Coenzyme A, as
previously described (Ruiz-Pesini et al. 1998). Protein
concentration was measured by the Lowry’s method.
Specific activities were expressed as nmol # min1 #
mg protein1. All chemicals were from Boehringer
Mannheim and Sigma Chemicals.
Statistical Analysis
The differences in haplogroup frequency distribution
between populations were assessed by the x2 test from
contingency tables. The contribution of individual table
cells to the x2 was done by post hoc analysis by the
following statistic:
O E
,
R CE ∗ 1 ∗ 1( ) ( )N N
where O is the observed frequency, C the column total,
R the row total, N the grand total and E is . This(CR)/N
form of standardized residual follows a standard normal
distribution.
Additionally, probabilities for the distribution of indi-
vidual haplogroups in asthenozoospermic and nonas-
thenozoospermic populations was estimated by means of
Fisher’s exact test from 2# 2 contingency tables, where
the frequency of all haplogroups but the one to be tested
was added. The differences between haplogroups in sem-
inogram parameters, spermatozoa vertical progression,
specific activity of NADH dehydrogenase (complex I),
succinate dehydrogenase (complex II), cytochrome c
oxidase (complex IV), and citrate synthase were assessed
by analysis of variance (ANOVA). Paired haplogroup dif-
ferences were assessed by the post hoc Fisher’s protected
least significant difference test (PLSD). All tests and cal-
culations were done with the statistical package StatView
5.0 for Macintosh (SAS Institute, Inc.).
Results
OXPHOS and Spermatozoa Motility
Our primary goal was the investigation of fixed
mtDNA variants with potential phenotypic conse-
quences in human sperm quality. Therefore, we focused
on the potential association between mtDNA and one
of the more relevant parameters of the spermiogram, the
motility of the spermatozoa. The spermatozoa have very
specialized mitochondria that are exclusively located in
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RESULTS AT SITEa
4529HaeII 8994HaeIII 14465AccI 10394DdeI 10397HaeIII 3592HpaI 1715DdeI 4577NlaIII
ND ND ND  ND ND ND ND
ND ND ND  ND ND  
ND ND ND  ND ND ND ND
ND ND ND  ND ND ND ND
ND ND ND  ND ND ND ND
 ND ND  ND ND ND ND
  ND  ND ND ND ND
    ND ND  
ND ND ND   ND ND ND
      ND ND
   / /ND   ND/
the midpiece of the cell at the position where the fla-
gellum is inserted. This localization strongly suggests
that ATP production by mitochondria can play a rele-
vant role in sperm motility. However, a surprising ab-
sence of consensus about the relevance of mitochondrial
OXPHOS in sperm motility (Cummins et al. 1998)
prompted us to investigate this aspect first. Figure 1
shows how the inhibition, by specific drugs, of the ac-
tivity of three OXPHOS complexes that are partially
encoded by mtDNA progressively impairs the quality of
sperm motility and finally blocks any flagellar move-
ment. These results demonstrate that the motility of hu-
man spermatozoa is fully dependent on the OXPHOS
functionality and confirm previous observations point-
ing in the same direction (Ford and Harrison 1981; Hal-
angk et al. 1985; Pascual et al. 1996; Ruiz-Pesini et al.
1998).
mtDNA Haplogroup and Sperm Motility Phenotype
Sperm samples from 545 donors were collected and
analyzed by standard procedures (see Methods). Then,
total DNA extraction and mtDNA PCR amplification,
followed by restriction enzyme analysis, were performed
to ascribe each donor to one of the different haplogroups
previously described (table 1). In this study, we have used
the nomenclature proposed by the Emory group (Wal-
lace 1995; Torroni et al. 1996, 1997; Brown et al. 1997)
and recently updated (Macaulay et al. 1999). In sum-
mary, and in good agreement with previous descriptions
of other white populations, 190% of the individuals be-
long to one of the previously known haplogroups (table
2), and their distribution was similar to those described
elsewhere (Richards et al. 1996; Torroni et al. 1996,
1997; Brown et al. 1997; Hofmann et al. 1997b, 1997c).
To investigate the potential genetic association be-
tween mtDNA variants and asthenozoospermia, we di-
vided our sample in two groups according to the motility
of the sperm cells: Asthenozoospermic (AP), individuals
with low sperm motility (! 50% of progressive sper-
matozoa) and Non-AP, individuals with normal sperm
motility ( 50%) (WHO 1992), and we estimated the
frequency of each haplogroup in the non-AP and AP
populations (table 2). Since the expected frequencies for
several haplogroups were !5, we have grouped the low-
represented ones (W, X, and I) according to their pro-
posed evolutionary proximity (Macaulay et al. 1999).
Furthermore, we have also grouped those of nonwhite
origin, haplogroups L (African) and M (Asian), with the
samples that we could not ascribe to any of the known
haplogroups (O). In this way, the minimum expected
frequency to ensure the accuracy in the x2 independence
test is reached (table 2). Contingency table analysis sug-
gests that the asthenozoospermic character may not be
independent on the mtDNA haplogroup ( ,2x p 13.873
, 6 df). When the contribution of the differentPp .0311
haplogroups to the x2 was examined, it could be ap-
preciated that T (x2 contribution 5.676) and H (x2 con-
tribution 5.106) mtDNAs were the main responsible for
the high x2. Furthermore, Fisher’s exact test also suggests
a significant deviation from the expected frequencies for
H ( ) and T ( ) mtDNA haplo-Pp .0019 Pp .0168
groups. In fact, a post hoc analysis on the cell contri-
bution to the x2 revealed that a significant deviation from
the expected frequency could be observed for the pres-
ence of mtDNA haplogroup H in normal individuals
(post hoc cell contribution 3.187, ). This wasPp .0014
also the case for the accumulation of T mtDNA hap-
logroup within the asthenozoospermic population (post
hoc cell contribution 2.453, ). None of thePp .0142
other haplogroups showed a frequency distribution in
AP and non-AP populations significantly deviated from
the expected values when a hypothesis of independence
was assumed.
We reevaluated the association between mtDNA hap-
logroups and motility phenotype by a semiquantitative
approach. Thus, we divided our samples by calculating
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Figure 1 Dependence of the sperm flagella movement on the
activity of the mitochondrial oxidative phosphorylation complexes.
The activity of several mitochondrial OXPHOS complexes was inhib-
ited by increasing concentrations of the indicated drug, and the pro-
portion of sperm cells able to move following a quick and straight
trajectory (open circles) or that manifest any kind of flagella activity
(close circles) was evaluated after 3 min in the presence of the drug
by microscopy count in a Neubauer chamber. Data represent average
 standard error of the mean (SEM) of four independent experiments.
Table 2
Observed Frequencies for Each Haplogroup in the Whole Sample
and in Asthenozoospermic versus Non-AP Populations
MTDNA
HAPLOGROUP
RESULTS IN POPULATIONa
Whole Sample Non-AP AP
n f n f n f
Hb 271 49.72 107 59.44 164 44.93
I 8 1.47 2 1.11 6 1.64
J 38 6.97 11 6.11 27 7.40
KU 106 19.45 31 17.22 75 20.55
L 7 1.28 2 1.11 5 1.37
M 8 1.47 1 0.56 7 1.92
O 39 7.16 10 5.56 29 7.95
Tc 31 5.69 4 2.22 27 7.40
V 21 3.85 7 3.89 14 3.84
W 6 1.10 2 1.11 4 1.10
X 10 1.83 3 1.67 7 1.92
Total 545 100.00 180 100.00 365 100.00
IWXd 24 4.40 7 3.89 17 4.66
LMOd 54 9.91 13 7.23 41 11.24
a Samples were considered as asthenozoospermic phenotype (AP)
when showing !50 % of progressive motile spermatozoa (WHO
1992). x2p 13.873 for haplogroup distribution vs. AP or Non-AP (6
df; ). n p indicates the number of individuals; f p thePp .0311
frequency expressed as percentage.
b Haplogroup H contribution to (Fisher’s exact test2x p 5.106
). Difference in frequency distribution from the expectedPp .0019
values for haplogroup H in non-AP population: Pp .0014
c Haplogroup T contribution to (Fisher’s exact2x p 5.676 Pp
). Difference in frequency distribution from the expected values.0168
for haplogroup T in the AP population: .Pp .0142
d IWX and LMO represent the added frequencies of I, W, and X
and of L, M, and O, respectively.
the frequency of the different haplogroups in three cat-
egories: nonasthenozoospermic (Non-AP;  50% of
progressive spermatozoa), moderate asthenozoospermic
phenotype (MAP;25% and !50% of progressive sper-
matozoa) and severe asthenozoospermic phenotype
(SAP; ! 25% of progressive spermatozoa) (table 3). Con-
tingency table analysis by the x2 test confirmed that the
degree of asthenozoospermia was not independent on
the mtDNA of the probands ( ,2x p 29.104 Pp
, 12 df). Again, T and H mtDNA haplogroups are.0038
the two major contributors to the x2 (T haplogroup con-
tribution to ; H haplogroup contribution2x p 14.955
to ). Moreover, a post hoc analysis on the2x p 5.165
cell contribution to the x2 shows that haplogroupHwas,
in fact, significantly overrepresented in non-AP individ-
uals (post hoc cell contribution 3.187, ),Pp .0014
whereas haplogroup T is very much accumulated in the
MAP group (post hoc cell contribution 3.977, Pp
). None of the other haplogroups showed an as-.00007
sociation with any of the motility phenotypes.
As an additional control of the observed association
between the motility phenotype and the mtDNA hap-
logroup, we divided our sperm-donors panel according
to a different parameter of the spermiogram, the con-
centration of sperm cells: oligozoospermic (OP), indi-
viduals showing reduced cell concentration (!20million/
ml); and non-OP, individuals showing normal sperm
concentration (20 million/ml) (WHO 1992). A similar
statistical approach determined that the oligozoospermic
character should be considered independent of the
mtDNA haplogroup ( , ; 6 df), and2x p 4.771 Pp .5736
none of the individual haplogroups showed a significant
association with OP or non-OP populations. Moreover,
when we reanalyzed our data for any potential rela-
tionship between severe oligozoospermia (!5 million
sperm cells/ml) and mtDNA haplogroup, no association
was observed ( ; ; 8 df).2x p 6.065 Pp .6400
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Table 3
Observed Frequencies for mtDNA Haplogroups in SAP, MAP, and Non-AP
MTDNA
HAPLOGROUP
RESULTS IN PHENOTYPEa
Non-AP MAP SAP All
n f n f n f n f
Hb 107 59.44 100 45.66 64 43.84 271 49.72
IWX 7 3.89 10 4.57 7 4.79 24 4.40
J 11 6.11 19 8.68 8 5.48 38 6.97
KU 31 17.22 39 17.81 36 24.66 106 19.45
LMO 13 7.22 22 10.05 19 13.01 54 9.91
Tc 4 2.22 23 10.50 4 2.74 31 5.69
V 7 3.89 6 2.74 8 5.48 21 3.85
Total 180 100.00 219 100.00 146 100.00 545 100.00
a Samples were considered as MAP when they showed !50% and 25% of pro-
gressive motile spermatozoa, and they were considered as SAP when they showed
!25% of progressive motile spermatozoa. for haplogroup distribution2x p 29.104
vs. SAP, MAP, or non-AP (12 df; ). n p the number of individuals; f pPp .0038
the frequency expressed as percentage.
b Haplogroup H contribution to . Difference in frequency distribution2x p 5.165
from the expected values for haplogroup H in non-AP population: .Pp .0014
c Haplogroup T contribution to . Difference in frequency distribution2x p 14.955
from the expected values for haplogroup T in AP population: .Pp .00007
The combination of the two characters of the sper-
miogram, motility and concentration of sperm cells, de-
fine four distinct phenotypes: 241 individuals were pure
asthenozoospermic A (pA), 25 were pure oligozoos-
permic (pO), 123 were asthenooligozoospermic (AO),
and 155 did not show any deficient phenotype and were
designated controls (C). Therefore, to confirm that the
asthenozoospermic character alone is responsible for the
observed associations, the distribution of the mtDNA
haplogroups in the control subpopulationwas compared
to that in the pure asthenozoospermic one (table 4). In
order to reach the minimal number of expected individ-
uals for a confident x2 analysis, the reduction in the
number of samples forced us to consider several hap-
logroups of lower interest together (IWX, LMO, and V)
in one that was called “Rest.” Despite of that, the x2-
independence test supports again the interpretation pro-
posed above, i.e., the non-random distribution of
mtDNA haplogroups with respect to the motility phe-
notype ( ; ; 8 df). Thus, a signifi-2x p 16.99 Pp .0302
cant accumulation of H mtDNA haplotypes within the
control population (post hoc test 3.282; ) andPp .001
of T mtDNA haplotypes within the MAP population
(post hoc test 2.650; ) was observed.Pp .008
The observed accumulation of H and T mtDNAs
within the non-AP and the MAP motility groups, re-
spectively, could be a secondary association determined
by an additional parameter of the seminogram. To in-
vestigate this possibility, we tested the potential variation
between haplogroups of several other parameters of the
seminogram. These evaluate a potential bias in the sam-
pling process (age of the donors, time between sample
collection, and analysis), differences in ejaculated vol-
ume, or pH as well as in the cellular composition of the
semen (spermatozoa concentration, spermatozoa vital-
ity, proportion of abnormal spermatozoa morphology,
and concentration of round cells). In addition, several
biochemical parameters that are used as markers of the
prostatic functionality (citric acid, zinc, magnesium, and
calcium concentration), seminal vesicle functionality
(fructose concentration) and epididimal functionality
(carnitine concentration) were evaluated. The number of
individual samples utilized for these analyses was vari-
able and dependent on their availability. Therefore we
also estimated if the observed accumulation of haplo-
groups T and H within the MAP and, respectively, the
non-AP population, was maintained in the subpopula-
tion utilized for the analysis of each parameter. Table 5
shows a summary of the results obtained and indicates
that none of the investigated parameters but motility
phenotype is significantly different between haplogroups
H and T.
For a large set of the samples ( ), we couldnp 223
perform an additional motility test consisting in themea-
surement of the maximum distance that the spermatozoa
population from different individuals are able to swim,
in 30 min; in a capillary tube introduced vertically into
the semen sample (vertical progression). This analysis
was performed before the mtDNA haplogroup of the
samples was determined and without knowing the sper-
miogram analysis. As shown in figure 2, the vertical
progression of spermatozoa was variable between hap-
logroups. Interestingly, it was maximum for haplogroup
H and minimum for haplogroup T being significantly
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Table 4
Observed Frequencies for mtDNA Haplogroups in Non-AP, Pure SAP, and Pure MAP
MTDNA
HAPLOGROUP
RESULTS IN POPULATIONa
Non-AP Pure MAP Pure SAP All
n f n f n f n f
Hb 95 61.29 70 42.94 37 47.44 202 51.01
J 8 5.16 16 9.82 5 6.41 29 7.32
KU 25 16.13 32 19.63 16 20.51 73 18.43
Rest 23 14.84 30 18.40 17 21.79 70 17.68
Tc 4 2.58 15 9.20 3 3.85 22 5.56
Total 155 100.00 163 100.00 78 100.00 396 100.00
a Samples were considered to be pure MAP when they show !50% and 25% of
progressive motile spermatozoa and 20 # 106 spermatozoa per milliliter. Samples
were considered to be pure SAP when they showed !25% of progressive motile sper-
matozoa and 20 # 106 spermatozoa per milliliter. for haplogroup dis-2x p 16.988
tribution vs. pure SAP, pure MAP, or Control (8 df; ). n p indicates thePp .0302
number of individuals; f p frequency, expressed as a percentage.
b Haplogroup H contribution to . Difference in frequency distribution from2x p 5.49
the expected values for haplogroup H in non-AP: .Pp .001
c Haplogroup T contribution to . Difference in frequency distribution from2x p 6.78
the expected values for haplogroup T in AP: .Pp .008
different ( , Fisher PLSD test). The rest of thePp .029
haplogroups showed an intermediate capacity of vertical
progression although the differences between them were
not significant.
Confirmation that the vertical progression is also a
good quantitative estimation of the degree of astheno-
zoospermia came from the fact that those individuals
classified as nonasthenozoospermic showed an average
spermatozoa vertical progression of 6.87  1.74 mm
( ), whereas in moderate asthenozoospermic wasnp 70
4.89  1.67 mm ( ) and severe asthenozoos-np 103
permic was 2.380  1.74 mm ( ). As expected,np 50
there is a strong association between vertical progression
and the motility phenotype (SAP, MAP, and non-AP)
established by the percentage of motile spermatozoa
( ; 2 df; ; ANOVA). Furthermore,Fp 101.086 P ! .0001
differences in vertical progression between paired groups
were always significant as estimated by the Fisher’s PLSD
post hoc test ( in all cases).P ! .0001
Finally, to discard any bias in the sampling of our
haplogroup T individuals, the hypervariable region I
(position 16083–16378 in the noncoding region of
mtDNA) of 29 of our 31 Ts was sequenced. Thus, we
were able to identify several main sublineages with 20
different haplotypes (fig. 3). Interestingly, they include
all the T branches described for the German population
(Hofmann et al. 1997c), showing that our T population
is truly representative of the white T haplogroup. In
addition, the non-AP as well as the SAP individuals were
scattered among the different branches of the T haplo-
type tree. These results strongly suggest that the accu-
mulation of T in the MAP population is due to the hap-
logroup itself rather than to a particular sublineage
within the haplogroup T.
Different OXPHOS Performance between Sperm
Samples Carrying H or T mtDNAs
In order to get some insights on the molecular mech-
anism underlying the observed association between
mtDNA haplogroups and spermatozoa motility, we first
tested the OXPHOS performance in sperm homogenate
of the 136 individuals from whom we had enough avail-
able sample. Those 136 samples represented a mix of
SAP, MAP, and non-AP (39, 58, and 39 samples, re-
spectively) and a variety of haplogroups H, J, KU, and
T (60, 17, 27, and 5, respectively). Samples belonging
to the remaining haplogroups (I, X, V, W, L, M, and O;
5, 3, 3, 1, 4, 4, and 7) were grouped together ( )np 27
and were called “Rest” for the purpose of statistical
analysis. As shown in figure 4, complex I–specific activ-
ity measured in spermatozoa homogenates was variable
between different haplogroups, being, on average, 22%
lower in samples carrying T mtDNAs than in those car-
rying H mtDNAs. However, this variability was not sig-
nificant enough to reject the independence hypothesis
between the mtDNA haplogroups and NADH DH ac-
tivity (ANOVA ), and no significant differencesPp .593
between paired haplogroups were observed. Since all T
samples fall in the MAP category, the difference in
NADH DH activity considering only MAP individuals
was also investigated. Again, a nonsignificant reduction
of the complex I activity of T individuals versus that in
H individuals could be observed (ANOVA ).Pp .873
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Figure 2 Vertical-progression analysis. Differences in the ability
of spermatozoa carrying different mtDNAs to swim from the semen
into a capillar tube in a period of 30 min. n is the number of samples,
and the asterisk (*) indicates significant differences between the dis-
tance of vertical progression for haplogroup T versus haplogroup H
carrying mtDNA samples ( ; Fisher’s PLSD test).Pp .029
Table 5
Differences in Seminal Parameters between H and T mtDNA Carrier Populations
PARAMETER
n
WHOLE
POPULATION
HAPLOGROUP
T VER-
SUS Ha
T IN
MAPb
H IN
NON-
APbAll H T H T
Age (years) 360 169 17 32.6  6.0 32.6  6.3 33.6  4.8 .4778 !.001 !.001
Preanalytic time (min) 235 109 12 45.9  14.7 44.1  12.9 47.9  18.8 .3933 .002 .002
Seminal volume (ml) 513 252 31 3.3  1.7 3.3  1.7 3.4  1.9 .7039 !.001 !.001
Seminal pH 317 156 18 7.7  .3 7.8  .3 7.8  .4 .4213 .004 .002
Prostatic markers:
Citric acid (mg/dl) 202 95 11 533  300 570  343 550  244 .8329 !.001 !.001
Zn (mg/dl) 201 95 11 10.8  6.3 11.3  6.4 11.9  6.2 .8082 !.001 !.001
Mg (mg/dl) 202 95 11 8.2  4.4 8.5  4.6 7.5  4.2 .8080 !.001 !.001
Ca (mg/dl) 202 95 11 35.4  14.6 37.5  15.6 33.6  12.6 .4035 !.001 !.001
Seminal vesicle marker:
Fructose (mg/dl) 202 95 11 295  132 281  142 344  164 .1383 !.001 !.001
Epididimal marker:
Carnitine (mM) 197 93 11 485  231 497  234 446  211 .4877 !.001 !.001
Cellular parameters:
Sperm concentration (million cells/ml) 544 270 31 48.4  44.1 51.4  46.3 40.9  30.6 .2084 !.001 !.001
Vital spermatozoa (%) 211 100 17 49.6  16.7 49.5  17.8 47.2  13.8 .6577 .006 .006
Abnormal spermatozoa (%) 238 119 17 50.7  17.0 48.4  16.8 52.1  14.9 .4082 !.001 !.001
Round cells (million cells/ml) 251 119 15 4.3  3.5 4.0  3.2 3.8  3.2 .7807 !.001 !.001
a Estimation of the potential signification (Fisher’s PLSD test) for the difference between the mean values of the indicated parameter for
H and T mtDNA carriers.
b Significance of the association of T and H individuals with the MAP and non-AP populations, respectively, for the subset of samples
included in the analysis of each seminal parameter.
On the contrary, ANOVA analysis indicated that com-
plex IV–specific activity showed a significant variability
between the different haplogroups regardless of the mo-
tility phenotype in the subpopulations included in the
analysis (ANOVA for total sample andPp .0031
for MAP individuals; fig. 4). Thus, T hap-Pp .0464
logroup showed the lowest COX activity when com-
pared with H mtDNA haplogroup. This difference was
significant by the Fisher’s PLSD post hoc test (Pp
for total sample and for MAP indi-.0184 Pp .0159
viduals). The other haplogroups showed intermediate
COX activity that were not (J and KU) or were signif-
icantly different (Rest, for total sample andPp .0016
, for MAP) from that estimated for the HPp .0116
haplogroup (fig. 4). In addition, small and nonsignificant
differences between haplogroups in the specific activity
of complex II (the only respiratory complex with all
subunits encoded by nuclear genes) and citrate synthase
(a mitochondrial matrix located enzyme) could be ob-
served (fig. 4).
Furthermore, when the activity of the different res-
piratory complexes was normalized to the activity of the
citrate synthase, an interesting figure arose (fig. 5). Both
complex I and complex IV showed high relative activity
in samples carrying the H mtDNA haplogroup and the
lowest relative activity in samples harboring the T
mtDNA. Thus, T samples showed 23% and 29% re-
ductions, respectively, in complexes I and IV, with re-
spect to H samples. However, these differences were not
statistically significant by the ANOVA test. Moreover,
the activity of complex II, when normalized by citrate
synthase, was virtually identical between the different
haplogroups, and, in particular, between H and T. De-
spite the absence of statistical significance, it should be
remarked that those complexes that are partially en-
coded by mtDNA (complex I and IV) showed a similar
reduction in their relative activity per mitochondria be-
tween haplogroups H and T. On the contrary, the com-
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Figure 3 Sequence analysis of mtDNA haplogroup T carriers. Nucleotide differences at the hypervariable region I (HVRI) of the noncoding
region of mtDNA that define 20 haplotypes in 29 individuals harboring the T haplogroup. The phenotype of the different individuals is indicated
as SAP (blackened circles) or non-AP (unblackened circles); all the other samples showed MAP (striped circles). Each individual is indicated by
a letter/number code.
plex that has no subunits encoded by mtDNA showed
similar activity in all haplogroups. Therefore, samples
of individuals belonging to the T and H mtDNA hap-
logroups seem to present the largest difference in sperm
OXPHOS performance between haplogroups.
Additional Haplogroup T–Specific mtDNA
Polymorphisms
The differences in OXPHOS performance between
haplogroups were not a consequence of haplogroup-spe-
cific differences in mtDNA level as estimated by ANOVA
analysis, since the proportion of mtDNA/nDNA be-
tween the different haplogroups was very similar (data
not shown). Several polymorphic markers that differ-
entiate the T haplogroup are located at genes that encode
complex I subunits (T4216C at ND1, A 4917G at ND2,
and G13368A at ND5) which promote either amino acid
substitutions (YrH at ND1 and DrN at ND2) or no
changes (ND5). These changes could be invoked to ex-
plain the apparently lower performance of complex I in
T mtDNA carrying individuals. However, these could
not explain the more significant reduction in complex
IV activity observed in T individuals. Therefore, to in-
vestigate the molecular reason why COX activity was
reduced in T samples, we sequenced the full set of COX
genes encoded in the mtDNA for one T individual. Three
alterations from the Cambridge sequence were detected.
One, the expected C7028T transition, was located in the
CO I gene (which is common to all white haplogroups,
with the exception of H) and is a synonymous mutation.
The second was located in the CO II gene and is also a
synonymous C7891T transition not previously de-
scribed. Finally, the third mutation, a G9559C trans-
version, was located in the CO III gene, and it implies
a variation from proline to arginine. This last mutation
has been recently reported as an error of the Cambridge
sequence (Andrews et al. 1999) and is not specific for
haplogroup T. Therefore, none of these polymorphisms
could justify the reduced COX activity associated with
T mtDNA.
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Figure 4 OXPHOS-activity analysis. Bar diagrams showing the differences in activity of two fully nuclear-encodedmitochondrial enzymes,
citrate synthase (CS, a mitochondrial-matrix enzyme) and succinate dehydrogenase (complex II) and two enzymatic complexes partially encoded
by mtDNA: NADH dehydrogenase (complex I) and cytochrome c oxidase (COX or complex IV). Bars represent specific enzyme activity (mean
 SEM) for the different haplogroups when either all (gray) or only MAP (crossed) individuals were considered. ANOVA test indicate the
absence of significant differences between haplogroups for CS, complex II, and complex I, as well as a significant difference for COX activity
when all ( ) or only MAP ( ) individuals were considered. Post hoc analysis by Fisher’s PLSD test reveals that T and RestPp .0031 Pp .0464
showed a significantly lower COX activity when compared with H, regardless of whether all or only MAP individuals were considered (P !
)..05
In addition, the accumulation of T mtDNA within the
asthenozoospermic population could be due to an in-
efficient mitochondrial ATP synthase activity (complex
V). Since the evaluation of the activity of complex V in
spermatozoa is very much compromised by the heavy
Dinein ATPase activity, we sequenced the mtDNA en-
coded ATP synthase subunits of one individual to search
for any T-specific polymorphic substitutions. Three mu-
tations were detected, all in the ATPase 6 gene. One, a
synonymous G8697A transition, was previously de-
scribed in another T individual and seems to be a hap-
logroup-specific polymorphism (Ohlenbusch et al.
1998). The second, an A8860G transition, was described
previously in other haplogroups, including H (Marzuki
et al. 1991; Ohlenbusch et al. 1998; Andrews et al.
1999). The third mutation was an A9037G transition
not described previously but not present in other T
individuals.
Mild reduction in OXPHOS activity also can be a
consequence of mutations in the mtDNA genes that en-
code for rRNAs or tRNAs. Thus, an homoplasmic mu-
tation at nt 7445 has been described that decreases the
amount of mitochondrial tRNASerUCN (Reid et al.
1994; Fischel-Ghodsian et al. 1995; Reid et al. 1997;
Guan et al. 1998). In cultured cells, this mutation is
associated with a moderate reduction in mitochondrial
protein synthesis and a relatively mild phenotype (Guan
et al. 1998). The fact that activity of complex I, as well
as that of complex IV, apparently was reduced in T sam-
ples also suggests that they could be the consequence of
a reduced performance in protein synthesis caused by a
haplogroup-associated mutation in tRNA genes. To test
this hypothesis, we sequenced the 22 tRNAs of one T
individual. Two mutations were detected: a T10463C
transition in the tRNA Arg gene within an uncommon
U/U base pair at the bottom of the acceptor stem that
becomes here U/C (fig. 6) and a G15928A transition in
the tRNA Thr gene that transforms the first base pair
at the anticodon stem into a non–standard Watson and
Crick base pair C/A (fig. 6). Both tRNA mutations were
previously described (MITOMAP), and it was proposed
that are haplogroup T–specific polymorphic sites (Ma-
caulay et al. 1999). In confirmation of that, they were
detected in all our T individuals. In addition, the
G15928A transition at the tRNA Thr gene was not pre-
sent in any of the 495 non-T individuals investigated,
as determined by RFLP analysis (see Material andMeth-
ods) and as confirmed by sequencing of the only three
samples that showed alterations in their RFLP pattern.
Further molecular analysis will be needed to determine
if any of these tRNA variants, or both synergically, in-
fluence mitochondrial protein synthesis in a way that
692 Am. J. Hum. Genet. 67:682–696, 2000
Figure 5 Bar diagrams showing the relative activity of three
respiratory complexes (complexes I and IV, partially encoded by
mtDNA, and complex II, fully encoded by nuclear genes) in each
haplogroup, when they are normalized by the activity of citrate syn-
thase. Data are given as mean  SEM in arbitrary units.
Figure 6 Haplogroup T–specific tRNA mutations. Sequencing
of all the tRNA genes of one individual showed, in two tRNAs, mu-
tations that were specific for the haplogroup T individuals: left,
A15928G transition at the top of anticodon stem of the tRNA Thr;
right, U10463C transition at the bottom of the acceptor stem of the
tRNA Arg.
could justify the lower COX activity found in T
mtDNA–carrying organelles.
Discussion
Two major conclusions can be drawn from the work
presented in this report. First, we have unequivocally
demonstrated that human spermatozoa motility is fully
dependent on the functionality of the OXPHOS system.
Second, we have obtained compelling evidence indicat-
ing that the spermatozoa-motility phenotype is condi-
tioned by the mtDNA haplogroup.
In particular, those probands carrying the H haplo-
group are significantly more frequent in populations
selected by their high sperm motility, and those carrying
the T haplogroup are accumulated in populations se-
lected by their reduced sperm motility. Haplogroup H
is the most common variant in white mtDNA popula-
tions (Richards et al. 1996; Torroni et al. 1996; Brown
et al. 1997; Hofmann et al. 1997a, 1997c; Torroni et
al. 1997). Therefore, in light of the direct dependence
of spermatozoa motility on the OXPHOS functionality
(Halangk et al. 1985; Pascual et al. 1996; Ruiz-Pesini
et al. 1998), it is reasonable to interpret the accumu-
lation of the H mtDNA haplogroup in the non-AP pop-
ulation as an indication of a robust genetic background
preventing against some OXPHOS weakness in sper-
matozoa. More interesting seems to be the increased
frequency of haplogroup T in the MAP population.
Haplogroup T is widely distributed among white pop-
ulations. Its frequency is very variable, ranging from
22% in Swedes to 12% in central Germans to 4.4% in
the Druze (Torroni et al. 1996, 1997; Hofmann et al.
1997c). From our results, it could be inferred that hap-
logroup T represents a weak genetic background that
can predispose to asthenozoospermia.
In support of this interpretation, a difference in sperm
COX-specific activity between samples harboringHand
T mtDNAs also has been observed. The interpretation
of the OXPHOS performance analysis should be done
with care. Several facts suggest that no dramatic dif-
ference should be expected between the activity of the
different respiratory complexes under each particular
mtDNA haplogroup. (1) The association of TwithMAP
and H with non-AP subpopulations, and, more quan-
titatively, the 27% reduction in vertical progression of
T versus H spermatozoa, suggests that the phenotypic
effect induced by the type of mtDNA, although signif-
icant, is mild. (2) A severe OXPHOS defect caused only
by an intrinsic characteristic of a particular mtDNA
should imply a very severe loss of motility and would
likely have phenotypic effects in other tissues. To our
knowledge, the only potentially relevant health problem
reported by a portion of the individuals included in this
study is the difficulty of the couple to get pregnant and,
in a significant portion of these couples, the origin of
the problems should be attributed to the female partner.
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On the contrary, if specific particularities of the sperm
OXPHOS system biogenesis were the main factor re-
sponsible for the association between low sperm mo-
tility and haplogroup T, either severe or moderate as-
thenozoospermic phenotype could be expected without
compromising the OXPHOS performance in other tis-
sues. (3) However, the relatively high frequency of the
T mtDNA in white populations strongly suggests that
the effect of this mtDNA in male fertility should not be
dramatic. This is true since the lack of selective pressure
against male mtDNA is not absolute because popula-
tions with a high proportion of otherwise healthy in-
fertile males, will reduce the successful pregnancy rate,
and the survival of the population would be compro-
mised. It should be mentioned here that MAP men must
be considered subfertile individuals, rather than infertile
ones (Baker 1994). Therefore, it is reasonable to expect
only mild OXPHOS differences between H and T
mtDNAs.
The determination of consistent small differences in
the activity of OXPHOS complexes between samples is
always compromised by the high intrinsic variability of
the enzymatic determinations. In fact, this has been also
difficult to establish in well-characterized pathogenic
homoplasmic mtDNAmutations—that is, those causing
nonsyndromic deafness (Prezant et al. 1993; Reid et al.
1994; Fischel-Ghodsian et al. 1995) or Leber’s optic
neuropathy (LHON) (Howell 1999) (see below). In
spite of that, in this work, we were able to detect sta-
tistically significant differences in the COX activity be-
tween individuals harboring the H mtDNA and those
harboring the T mtDNA. The difference is maintained
when the activity is normalized by a mitochondrial-
matrix enzyme activity (citrate synthase), although the
statistical significance is lost. Nevertheless, there are ad-
ditional indications that made us to propose that the
COX activity—and probably the NADH DH activity
as well—are truly different between spermatozoa har-
boring H and T mtDNAs. First, there is a coherent
relationship between the accumulation of H or T in-
dividuals within the non-AP and AP populations, re-
spectively, and the OXPHOS figures. Second, and more
importantly, when normalized by citrate synthase, there
is a positive correlation between the activity of the com-
plexes partially encoded by mtDNA (complex I, 23%
decreased in T vs. H; complex IV, 29% decreased in T
vs. H). On the contrary, this correlation is not main-
tained with the only complex that has all its subunits
encoded by nuclear genes (complex II, 1% increased in
T vs. H). Very interestingly, the amount of reduction in
complex I or complex IV needed to affect overall cell
respiration in cultured human cells, and, therefore, ATP
production is 20% for COX (Villani and Attardi 1997)
and ∼20% for NADH DH (Bai et al. 2000). Thus, the
estimated reduction in OXPHOS performance in T ver-
sus H mtDNA backgrounds seems to be sufficient to
induce differences in overall respiration rate and ATP
production. Then, the relative lower ATP production
capacity of spermatozoa harboring T mtDNA, in a sit-
uation of high energy demands (motile spermatozoa),
would be the cause of the observed differences in the
motility of the spermatozoa. Therefore, although we
still must be cautious in the interpretation of this data,
we strongly believe that they indicate that a minor, but
consistent, general difference between the OXPHOS
performance of spermatozoa harboringH or TmtDNAs
explains their association with populations showing
variable degree of sperm-motility capacity.
If this interpretation is correct, it is still necessary to
understand how established mtDNA haplogroups (like
T) can favor asthenozoospermia and not obviously in-
volve other tissues. It could be that some particular char-
acteristics of spermatozoa (e.g., nuclear-encoded sperm-
specific OXPHOS subunits, etc.) make them especially
sensitive to particular haplogroups. Therefore, this sen-
sitivity would be not only an intrinsic characteristic of
a particular mtDNA, but also a consequence of the spe-
cific characteristics of the biogenesis of the sperm OX-
PHOS system. Alternatively, it could happen that, in
fact, some haplogroups promote a reduction in OX-
PHOS performance, albeit a very mild one in normal
circumstances. Thus, only in the presence of environ-
mental insults and/or certain nuclear backgrounds will
the OXPHOS activity associated with a particularly in-
efficient mtDNA haplogroup drop below the pathogenic
threshold. On the contrary, a more robust haplogroup
will keep the OXPHOS activity over such a threshold
in similar circumstances. It is, then, a plausible hypoth-
esis that one of the more demanding OXPHOS activities
(e.g., flagellar movement) will be affected first. More-
over, this would also imply that, under certain circum-
stances, this lower performance could be further am-
plified and could promote defects other than moderated
asthenozoospermia.
Tissue specificity and variable degree of penetrance
are hallmarks of mtDNA mutation–dependent disor-
ders, most typically of those associated with homo-
plasmic mtDNA mutations that cause nonsyndromic
deafness (Prezant et al. 1993; Reid et al. 1994; Fischel-
Ghodsian et al. 1995) or LHON (for review, see Howell
[1999]). The use of cellular models for the investigation
of an homoplasmic mtDNA mutation at position 7445,
affecting tRNA Ser (UCN) precursor processing, a non-
syndromic deafness–causing mutation, has revealed a
mild biochemical phenotype (Guan et al. 1998) or a
complete absence of one (Reid et al. 1997). However,
a clear defective molecular phenotype could be observed
in all cases: a severe reduction in the level of tRNA Ser
(UCN) (Reid et al. 1997; Guan et al. 1998). On the
other hand, a potential influence of the nuclear context
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in the expression of the biochemical defects associated
with a mitochondrial 12S rRNA mutation causing also
nonsyndromic deafness has been proposed (Guan et al.
1996). Interestingly enough, it has also been proposed
that, at least in some families, the latest mutation con-
fers susceptibility to aminoglycoside-induced ototoxic-
ity (Prezant et al. 1993). Therefore, the molecular con-
sequence of a mild (and homoplasmic) mtDNA
mutation is transformed into a biochemical defect only
after environmental insults, in susceptible nuclear back-
grounds, and/or in specific cellular types. Despite that,
the primary molecular cause of the disease is the
mtDNA mutation. Thus, analysis of the expression of
well-characterized homoplasmic pathogenic mtDNA
mutations can illustrate the potential phenotypic con-
sequences, although milder than those of such muta-
tions, of some mtDNA haplogroups.
Additional observations give support to the interpre-
tation that mtDNA haplogroup T is intrinsically prone
to development of OXPHOS defects. DIDMOAD is a
rare human disease characterized by diabetes insipidus,
diabetes mellitus, optic atrophy and deafness, and it can
be caused by defects in both nuclear and mitochondrial
genomes (Ro¨tig et al. 1993; Polymeropoulos et al.
1994). Very interestingly, a group of eight DIDMOAD
patients were found to be preferentially associated with
haplogroup T (Hofmann et al. 1997b, 1997c). In ad-
dition, an increased frequency of TmtDNA amongmul-
tiple sclerosis (MS) patients has been described (Kalman
et al. 1995; Mayr-Wohlfart et al. 1996).
The demonstration of negative (H) as well as positive
(T) association of mtDNA haplogroups with astheno-
zoospermia strongly supports a model in which mtDNA
haplogroups could contribute differentially to the per-
formance of the OXPHOS system. In fact, it is intrigu-
ing that other mtDNA haplogroups were asymmetri-
cally distributed between AP and non-AP populations
and showed differences in COX-specific activity. It is
also plausible that only certain sublineages within a par-
ticular haplogroup may be phenotypically relevant.
Therefore, further investigation, with a more extended
sample, will be needed to establish definitively the po-
tential influence of other white mtDNA haplogroups.
Nevertheless, a tendency has been observed suggesting
that mtDNA haplogroups, at first thought to be phe-
notypically indistinguishable, could have OXPHOS
phenotypic consequences and be involved in human
pathology.
In this respect, the existence of tissue-specific selective
pressures for different polymorphic mouse mtDNA var-
iants has been recently proposed (Jenuth et al. 1997).
There is also an increasing amount of evidence sug-
gesting that the penetrance of two of the three common
primary LHON mutations is significantly increased in
haplogroup J (Brown et al. 1997; Hofmann et al. 1997b,
1997c; Torroni et al. 1997). In addition, the positive
and negative associations of haplogroups T and H with
asthenozoospermia found in this report, the prevalence
of haplogroup T in DIDMOAD and MS patients men-
tioned above (Kalman et al. 1995; Mayr-Wohlfart et al.
1996; Hofmann et al. 1997b, 1997c), the accumulation
of haplogroup U in occipital stroke (Majamaa et al.
1998), and the J haplogroup in human centenarians (De
Benedictis et al. 1999) also point in the same direction.
Asthenozoospermia is considered a major cause of
untreatable male subfertility (Baker 1994). The role of
haplogroup T in promoting asthenozoospermia is prob-
ably related to an intrinsic higher sensitivity of the OX-
PHOS energy production to a variety of environmental
or genetic factors. Thus, this mtDNA background could
be a secondary, but relevant, contributing factor in at
least 7%–10% of the asthenozoospermic males. More-
over, it is very likely that future studies will extend fur-
ther the implication of both mtDNA- and nuclear-en-
coded OXPHOS genes as a major cause of sperm
dysfunction (Følgero et al. 1993; Frank andHurst 1996;
Kao et al. 1995; St. John et al. 1997; Zeviani and An-
tozzi 1997; Cummins et al. 1998; Ruiz-Pesini et al.
1998). Then, the isolation of well-defined genetic back-
grounds that are positively or negatively associated with
asthenozoospermia can contribute to understanding of
the causes of male infertility and can help to better de-
fine therapeutic strategies.
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